LSRI Delisted to Pin Sheets!!. YES! KEEP THE HEAT ON!!

[Guest guest]

LSRI Drops to Pink Sheets amid Animal Rights Action

USA: February 10, 2006

 

NEW YORK - Embattled animal testing lab Life Sciences Research Inc,

target of an intensive protest campaign by animal rights activists,

was forced to start trading shares on the Pink Sheets this week,

five months after it expected to be listed on the New York Stock

Exchange.

 

" Delisting them to the Pink Sheets is not enough, so we are now

moving into next stage of the campaign, which is getting them

delisted from the Pink Sheets, " Camille Hankins, co-founder of New

York-based Win Animal Rights (WAR), said on Wednesday.

" The prize is to close down LSRI and stop that killing. "

 

Life Sciences officials could not immediately be reached for

comment.

 

The company, which does animal research for the pharmaceutical and

biotechnology industry, was set to join the Big Board in September,

when the NYSE suddenly and without explanation pulled the plug on

the listing.

 

A month later, the company was still hoping to join the NYSE as

promised.

 

But the campaign of intimidation and threats by animal rights

activists led to the resignation of the company's primary market

maker, Legacy Trading, and Life Sciences Research suffered the

indignity of being dropped to trading on the Pink Sheets.

 

A Pink Sheets official, informed of WAR's aim to get the company

delisted from the Pink Sheets, said there was nothing he could do

about it.

 

" We are not a regulator, " said the official, who asked that his name

not be used.

 

He said the only way a company can be removed from the Pink Sheets

was if the US Securities and Exchange Commission suspends trading or

if brokers were to stop trading the company's shares.

 

Hankins said her group would continue its picketing protests against

the company on almost a daily basis. The group, which accuses LSRI

of profiting by the suffering and killing of animals, also plans to

make executives of biotech companies attending a major conference in

New York next week walk a gauntlet of protesters.

 

WAR activists have also threatened to step up their campaign by

staging protests at the offices and homes of executives of Life

Sciences' major investors and customers, including drug makers

Pfizer Inc, GlaxoSmithKline Plc, Novartis AG and Roche Holding AG .

 

Previous protests have taken place at the homes of LSRI's investors

and market makers.

 

Another animal rights group, the Animal Liberation Front, claimed

responsibility for spray-painting slogans across the walls of two

New York-area yacht clubs frequented by employees of a Wall Street

firm that was going to trade shares of Life Sciences. The firm then

changed its mind.

 

Before the planned NYSE listing, contact information for hundreds of

NYSE employees appeared on the Stop Huntingdon Animal Cruelty Web

site (www.shac.net).

 

Life Sciences is the parent of British-based Huntingdon Life

Sciences, which has long been a target of UK animal rights

activists.

 

LSRI shares closed down 10 cents at $11.30 Wednesday. Shares were

trading for about $18 on the Nasdaq Bulletin Board in September.